| Literature DB >> 26221039 |
Rangasudhagar Radhakrishnan1, Yixuan Li1, Shengyan Xiang2, Fenghua Yuan3, Zhigang Yuan1, Elphine Telles1, Jia Fang1, Domenico Coppola4, David Shibata4, William S Lane5, Yanbin Zhang3, Xiaohong Zhang6, Edward Seto7.
Abstract
MutS homolog 2 (MSH2) is an essential DNA mismatch repair (MMR) protein. It interacts with MSH6 or MSH3 to form the MutSα or MutSβ complex, respectively, which recognize base-base mispairs and insertions/deletions and initiate the repair process. Mutation or dysregulation of MSH2 causes genomic instability that can lead to cancer. MSH2 is acetylated at its C terminus, and histone deacetylase (HDAC6) deacetylates MSH2. However, whether other regions of MSH2 can be acetylated and whether other histone deacetylases (HDACs) and histone acetyltransferases (HATs) are involved in MSH2 deacetylation/acetylation is unknown. Here, we report that MSH2 can be acetylated at Lys-73 near the N terminus. Lys-73 is highly conserved across many species. Although several Class I and II HDACs interact with MSH2, HDAC10 is the major enzyme that deacetylates MSH2 at Lys-73. Histone acetyltransferase HBO1 might acetylate this residue. HDAC10 overexpression in HeLa cells stimulates cellular DNA MMR activity, whereas HDAC10 knockdown decreases DNA MMR activity. Thus, our study identifies an HDAC10-mediated regulatory mechanism controlling the DNA mismatch repair function of MSH2.Entities:
Keywords: DNA mismatch repair; histone acetylase; histone deacetylase (HDAC); histone deacetylase inhibitor (HDAC inhibitor) (HDI); post-translational modification (PTM)
Mesh:
Substances:
Year: 2015 PMID: 26221039 PMCID: PMC4566250 DOI: 10.1074/jbc.M114.612945
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157